STOCK TITAN

Crescent Capital Bdc Inc Financials

CCAP
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Crescent Capital Bdc Inc (CCAP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral
4/9

Crescent Capital Bdc Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Cash-Backed
2.17x

For every $1 of reported earnings, Crescent Capital Bdc Inc generates $2.17 in operating cash flow ($74.7M OCF vs $34.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk
-1.7x

Crescent Capital Bdc Inc earns $-1.7 in operating income for every $1 of interest expense (-$98.7M vs $57.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
$34.5M
YoY-53.1%
5Y CAGR-8.8%

Crescent Capital Bdc Inc reported $34.5M in net income in fiscal year 2025. This represents a decrease of 53.1% from the prior year.

EPS (Diluted)
$1.81
YoY-24.6%
5Y CAGR+0.1%

Crescent Capital Bdc Inc earned $1.81 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 24.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$5.0M
YoY-50.2%
5Y CAGR+23.6%

Crescent Capital Bdc Inc held $5.0M in cash against $873.8M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
37M
YoY-0.2%

Crescent Capital Bdc Inc had 37M shares outstanding in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
4.9%
YoY-5.1pp
5Y CAGR-4.9pp

Crescent Capital Bdc Inc's ROE was 4.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.1 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$1.3M
5Y CAGR-9.6%

Crescent Capital Bdc Inc spent $1.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
N/A

CCAP Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A -$24.1M+6.1% -$25.7M-2.8% -$25.0M N/A -$27.4M-2.3% -$26.8M-0.5% -$26.7M
Interest Expense N/A $13.9M-8.4% $15.2M+3.5% $14.6M N/A $16.1M+1.1% $15.9M+2.1% $15.6M
Income Tax N/A $0 $0-100.0% $6K N/A $155K $0 N/A
Net Income N/A $7.1M-52.7% $15.0M+284.6% $3.9M N/A $15.3M-25.1% $20.4M-27.2% $28.0M
EPS (Diluted) N/A $0.460.0% $0.46+2.2% $0.45 N/A $0.64+8.5% $0.59-6.3% $0.63

CCAP Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $1.6B-0.3% $1.6B-1.6% $1.7B-0.7% $1.7B+0.6% $1.7B+0.7% $1.6B-1.6% $1.7B+3.2% $1.6B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $5.0M-12.8% $5.8M-40.6% $9.7M-19.1% $12.0M+18.8% $10.1M-40.7% $17.1M+55.1% $11.0M+63.4% $6.7M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $916.1M+0.3% $913.6M-1.7% $929.7M-1.0% $939.4M+2.6% $915.6M+2.2% $896.2M-2.6% $920.0M+5.9% $868.7M
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $873.8M-0.2% $875.3M-1.4% $887.3M-1.7% $903.0M+3.1% $875.8M+2.2% $857.2M-2.6% $879.9M+5.8% $831.4M
Total Equity $706.0M-1.1% $714.1M-1.5% $724.7M-0.3% $727.1M-1.8% $740.6M-1.1% $748.8M-0.5% $752.4M+0.1% $751.7M
Retained Earnings -$251.0M-2.6% -$244.7M-4.4% -$234.4M-1.0% -$232.0M-6.2% -$218.5M-0.6% -$217.1M-1.7% -$213.5M+0.3% -$214.2M

CCAP Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $22.6M-26.4% $30.8M-15.6% $36.4M+340.9% -$15.1M-423.6% -$2.9M-106.2% $46.9M+290.5% -$24.6M-162.4% $39.5M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow -$18.9M+34.9% -$29.1M+29.0% -$40.9M-745.2% $6.3M+27.7% $5.0M+111.0% -$45.3M-257.3% $28.8M+190.1% -$31.9M
Dividends Paid $15.6M-10.6% $17.4M-0.1% $17.4M0.0% $17.4M-4.1% $18.2M-3.9% $18.9M-1.9% $19.3M+2.0% $18.9M
Share Buybacks $1.0M N/A N/A N/A N/A N/A N/A N/A

CCAP Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A 1.0%-1.1pp 2.1%+1.5pp 0.5% N/A 2.0%-0.7pp 2.7%-1.0pp 3.7%
Return on Assets N/A 0.4%-0.5pp 0.9%+0.7pp 0.2% N/A 0.9%-0.3pp 1.2%-0.5pp 1.7%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 1.24+0.0 1.230.0 1.22-0.0 1.24+0.1 1.18+0.0 1.14-0.0 1.17+0.1 1.11
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Yes, Crescent Capital Bdc Inc (CCAP) reported a net income of $34.5M in fiscal year 2025.

Crescent Capital Bdc Inc (CCAP) reported diluted earnings per share of $1.81 for fiscal year 2025. This represents a -24.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Crescent Capital Bdc Inc (CCAP) had $5.0M in cash and equivalents against $873.8M in long-term debt.

Crescent Capital Bdc Inc (CCAP) has a return on equity of 4.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Crescent Capital Bdc Inc (CCAP) generated $74.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Crescent Capital Bdc Inc (CCAP) had $1.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Crescent Capital Bdc Inc (CCAP) spent $1.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Crescent Capital Bdc Inc (CCAP) had 37M shares outstanding as of fiscal year 2025.

Crescent Capital Bdc Inc (CCAP) had a debt-to-equity ratio of 1.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Crescent Capital Bdc Inc (CCAP) had a return on assets of 2.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Crescent Capital Bdc Inc (CCAP) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Crescent Capital Bdc Inc (CCAP) has an earnings quality ratio of 2.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Crescent Capital Bdc Inc (CCAP) has an interest coverage ratio of -1.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top